Pharmacokinetics of Cefuroxime in Synovial Fluid.

about

Pharmacokinetics of Cefuroxime in Synovial Fluid.

Item

http://www.wikidata.org/entity/Q47265801

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@en

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@nl

type

Item

label

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@en

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@nl

prefLabel

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@en

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@nl

P1476

Pharmacokinetics of Cefuroxime in Synovial Fluid.

@en

P2093

A Appelt

http://www.w3.org/2001/XMLSchema#string

C Kloft

http://www.w3.org/2001/XMLSchema#string

D Burau

http://www.w3.org/2001/XMLSchema#string

D Marhofer

http://www.w3.org/2001/XMLSchema#string

K Sarahrudi

http://www.w3.org/2001/XMLSchema#string

R Schwameis

http://www.w3.org/2001/XMLSchema#string

S Syré

http://www.w3.org/2001/XMLSchema#string

P2860

Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.

Microdialysis in peripheral tissues.

Science, medicine, and the future: Microdialysis.

Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.

Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.

Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections

Tissue pharmacokinetics of cefazolin in patients with lower limb infections.

Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole.

P31

scholarly article

P356

10.1128/AAC.00992-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Markus Alexander Zeitlinger

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28784675

http://www.w3.org/2001/XMLSchema#string

P932

5610482

http://www.w3.org/2001/XMLSchema#string